| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |